Prostate News Archive
09-Nov-2007
Antisense Therapeutics Announces ATL1101 Enters Pre-clinical Research in Prostate Cancer (ANP.AX, 00780668, 20071108) (Aspect Huntley via Yahoo!7 Finance)
Antisense Therapeutics announced that it is commencing a collaborative research programme with one of the worlds leading researchers in the field of prostate cancer. The collaboration with Prof. Martin Gleave, Distinguished Professor, Department of Urological Sciences, University of British Columbia and Director of The prostate Centre at Vancouver General Hospital, will examine the potential of ... Experimental Drug Fights Prostate Cancer (MedicineNet.com)
Title: Experimental Drug Fights prostate Cancer Category: Health News Created: 11/8/2007 2:00:00 AM Last Editorial Review: 11/8/2007 2:00:01 AM Experimental Drug Fights Prostate Cancer (iVillage Total Health)
In mice, an investigational agent called VN/14-1 proved effective in treating human prostate cancer, say researchers at the University of Maryland in Baltimore. The five-week study found that daily injections of VN/14-1 in mice implanted with human prostate cancer cells resulted in up to a 50 percent reduction in tumor volume. Experimental Drug Fights Prostate Cancer (HealthDay via Yahoo! News)
WEDNESDAY, Nov. 7 (HealthDay News) -- In mice, an investigational agent called VN/14-1 proved effective in treating human prostate cancer, say researchers at the University of Maryland in Baltimore.
Back to Prostate News Archive
